Pentwater Capital Management LP 13D/13G Filings for Blueprint Medicines Corporation (BPMC)

Pentwater Capital Management LP 13D and 13G filings for Blueprint Medicines Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
4:10 pm
Purchase
2025-06-3013GBlueprint Medicines Corporation
BPMC
Pentwater Capital Management LP3,900,000
6.000%
3,900,000increase
(New Position)
Filing